CLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CLS is a strong company with powerful AI/data-center growth, but it is not a good immediate buy right now for a Beginner long-term investor with $50,000-$100,000 who is unwilling to wait. The stock has already had a massive run, the near-term technical setup is weakening, and the current price is below key resistance but still above support, making this a poor rush-in entry. My direct view: hold off and wait for a better pullback or a fresh technical reset rather than buying today.
The longer-term trend remains bullish because SMA_5 is above SMA_20 and SMA_20 is above SMA_200, which supports an uptrend. However, short-term momentum has deteriorated: MACD histogram is -3.169 and negatively expanding, showing weakening momentum, while RSI_6 at about 40 is neutral to slightly soft. Price closed at 384.94, below the pivot of 396.22 and well under resistance at 428.69, with support at 363.75. This means the stock is not breaking out right now and may still drift lower before stabilizing.
Celestica is benefiting from AI infrastructure demand, hyperscaler spending, and optical/networking growth. News highlights a 345% stock surge tied to AI-driven revenue growth, Q1 revenue of $4.05 billion, new AMD-related business, and a raised full-year revenue guide from $17 billion to $19 billion. Analyst sentiment is strongly positive overall, with multiple firms raising targets and several calling the pullback a buy-the-dip opportunity. Hedge funds are also buying aggressively, with buying up 309.07% over the last quarter.
The stock had a sharp regular-session drop of 6.92%, and the recent price action suggests the market may be digesting a very large prior run-up. Similar-pattern data points to near-term downside probability over the next week and month. On the technical side, MACD is weakening and the price is below the pivot. Insider activity is neutral, and there is no AI Stock Picker or SwingMax signal today. No recent congress trading data was available.
In Q1 2026, Celestica delivered very strong growth. Revenue rose 52.80% year over year to 4.047 billion, net income increased 146.29% to 212.3 million, EPS climbed 147.30% to 1.83, and gross margin improved to 10.53%, up 6.15% year over year. That is a strong latest-quarter performance and it supports the long-term growth story, especially for the 2026-2027 ramp.
Analyst sentiment is clearly bullish overall, with multiple target raises clustered around the Q1 report. Recent actions include Buy/Outperform ratings and target increases from Rothschild & Co Redburn, CIBC, RBC, JPMorgan, Susquehanna, Citi, Barclays, and TD Securities. Targets range from $400 to $510, with many firms citing AI networking demand, higher guidance, and stronger 2027 visibility. The pros view is that CLS has expanding demand, better profitability, and major upside in AI infrastructure. The main con is that some of the opportunity already appears priced in, and one major house, UBS, still sits at Neutral.
